Trustees Of Columbia University In The City Of New York Vigil Neuroscience, Inc. Transaction History
Trustees Of Columbia University In The City Of New York
- $46.9 Million
- Q4 2023
A detailed history of Trustees Of Columbia University In The City Of New York transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Trustees Of Columbia University In The City Of New York holds 192,973 shares of VIGL stock, worth $723,648. This represents 1.39% of its overall portfolio holdings.
Number of Shares
192,973
Previous 192,973
-0.0%
Holding current value
$723,648
Previous $1.04 Million
37.31%
% of portfolio
1.39%
Previous 2.05%
Shares
1 transactions
Others Institutions Holding VIGL
# of Institutions
57Shares Held
26.6MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$21.9 Million3.11% of portfolio
-
Northpond Ventures, LLC4.21MShares$15.8 Million58.42% of portfolio
-
Artal Group S.A. Luxembourg, N41.83MShares$6.86 Million0.46% of portfolio
-
Bvf Inc San Francisco, CA1.81MShares$6.8 Million0.22% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L31.69MShares$6.35 Million0.99% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $106M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...